Header Logo

Connection

Alan Landay to Dose-Response Relationship, Immunologic

Back to Details
This is a "connection" page, showing publications Alan Landay has written about Dose-Response Relationship, Immunologic.
Alan Landay
Connection Strength
0.009
Dose-Response Relationship, Immunologic
  1. Recombinant human interleukin-1 receptor type I in the treatment of patients with active rheumatoid arthritis. Arthritis Rheum. 1996 Feb; 39(2):257-65.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.